However , in patients who were co-administered AZ , the C0 values of tacrolimus were higher in patients with the CYP3A5 * 3 / * 3 allele than with the CYP3A5 * 1 allele ( P = 0.034 ) , although daily doses of Tac-QD in patients with CYP3A5 * 3 / * 3 were significantly lower than those with the CYP3A5 * 1 allele ( P = 0.041 ) .